Viyash Scientific: The financial results for the period ended September 30, 2026

What happened

Viyash Scientific (VIYASH) filed a disclosure with the exchanges on 13 November 2026 at 05:36 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Viyash Scientific is a small-cap company in the Healthcare sector, with a market value of about ₹11,154 crore.

The stock last traded at ₹255.3, against a 52-week range of ₹178.1–₹298 (14.3% below the high).

Before this filing the shares had moved +8.0% over the month and −4.4% over three months. Average daily turnover over the last 20 sessions was about ₹50.83 crore.

Promoters held 61.31% at the end of Q1 FY27. Foreign institutions owned 4.50% and domestic institutions 3.75%.

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.8% over five days; 58% of them rose the next day.

Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 13 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• Viyash Scientific ESOP Allotment: 2,28,408 Shares Issued — Kalkine India, 2 Nov 2026
• Viyash Scientific (NSE:VIYASH) Approves Allotment of 2,28,408 Shares Under Employee Stock Option Plans — Kalkine Media, 2 Nov 2026
• Viyash Scientific (NSE:VIYASH) Approves Allotment of 2,28,408 Shares Under ESOP Plans — Kalkine Media, 2 Nov 2026
• Viyash Scientific announces Q2 FY27 financial results — InvestyWise, 13 Nov 2026
• Viyash Scientific Limited reports Q2 FY27 results with approved financial statements — InvestyWise, 13 Nov 2026

Source

• Exchange filing (PDF)